Hoba Therapeutics
PrivateLast Round
Series A
Dec 11, 2023
Total Funding Raised
$30.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hoba Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Series A round in December 2023.
Hoba Therapeutics is a biotechnology company that develops novel therapeutic proteins for the treatment of chronic neuropathic pain and sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hoba Therapeutics Comparables
Compare Hoba Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmNovo AB | 83% | |
| Algiax Pharmaceuticals | 78% | |
| Latigo Biotherapeutics | 78% |
For institutional investors. Book with your work email.
Hoba Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 11, 2023 | ||||
| Grant | Jun 16, 2021 | ||||
| Grant | Sep 20, 2018 | ||||
| Seed | Nov 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hoba Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Medical Incubator Japan | Series A |
| Indaco Venture Partners SGR | Series A |
| Eir Ventures | Series A |
| Novo Holdings | Series A |
| The Export and Investment Fund of Denmark | Series A |
| Borean Innovation | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 580% MoM, from 40 to 272.
- Jul 3, 2025
Monthly visitors grew 371% MoM, from 255 to 1.2K.
For institutional investors. Book with your work email.
Hoba Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hoba Therapeutics's valuation, stock price, and market status.
Is Hoba Therapeutics a public or private company?
Hoba Therapeutics is a private company.
What is the current stock price of Hoba Therapeutics?
Hoba Therapeutics is a private company, so its shares have no public market price. Caplight tracks Hoba Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hoba Therapeutics worth (valuation)?
Valuation information for Hoba Therapeutics is not publicly available.
Can I buy Hoba Therapeutics stock?
Hoba Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hoba Therapeutics's last funding round?
Hoba Therapeutics's most recent funding round was Series A on December 11, 2023.
Who are the main investors in Hoba Therapeutics?
Key investors in Hoba Therapeutics include Innovation Fund Denmark, Medical Incubator Japan, Indaco Venture Partners SGR, European Innovation Council Fund.
Will Hoba Therapeutics IPO soon?
No public IPO plans have been announced for Hoba Therapeutics.
How can I track Hoba Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Hoba Therapeutics's shares on secondary markets.